Hedy Kindler to Esophagogastric Junction
This is a "connection" page, showing publications Hedy Kindler has written about Esophagogastric Junction.
Connection Strength
0.070
-
Phase II trial of gemcitabine in patients with previously untreated metastatic cancer of the esophagus or gastroesophageal junction. Ann Oncol. 2000 Sep; 11(9):1161-4.
Score: 0.047
-
A multicenter, phase II study of bortezomib (PS-341) in patients with unresectable or metastatic gastric and gastroesophageal junction adenocarcinoma. Invest New Drugs. 2011 Dec; 29(6):1475-81.
Score: 0.023